138 related articles for article (PubMed ID: 1153615)
1. Acute sedative properties of SKF 525A in rats: implications for its use as a metabolism inhibitor in the study of psychoactive drugs.
Goudie AJ; Kelley M; Taylor M; Wheeler TJ
Psychopharmacologia; 1975; 41(3):291-4. PubMed ID: 1153615
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the metabolism of cocaine by SKF-525A.
Estevez VS; Ho BT; Englert LF
Res Commun Chem Pathol Pharmacol; 1977 May; 17(1):179-82. PubMed ID: 877402
[TBL] [Abstract][Full Text] [Related]
3. Opiate properties of SKF 525A.
Ho TK; LaBella FS; Pinsky C
Can J Physiol Pharmacol; 1978 Aug; 56(4):550-4. PubMed ID: 210915
[TBL] [Abstract][Full Text] [Related]
4. Alterations in tissue distribution of chlordecone (kepone) in the rat following phenobarbital or SKF-525A administration.
Aldous CN; Chetty CS; Desaiah D
J Toxicol Environ Health; 1983 Mar; 11(3):365-72. PubMed ID: 6188850
[TBL] [Abstract][Full Text] [Related]
5. Potentiation by SKF 525A of the pressor responses to catecholamines, oxytocin and carotid occlusion in rats.
Krstić MK
Arch Int Pharmacodyn Ther; 1984 May; 269(1):52-62. PubMed ID: 6466007
[TBL] [Abstract][Full Text] [Related]
6. Influence of psychotropic drugs and beta-diethylaminoethyl-diphenylpropylacetate (SKF 525-A) on mescaline-induced behavior and on tissue levels of mescaline in mice.
Shah NS
Biochem Pharmacol; 1976 Mar; 25(5):591-7. PubMed ID: 8055
[No Abstract] [Full Text] [Related]
7. Blockade by SKF 525A of the rat sympathetic ganglia and the adrenal medulla.
Krstić MK
Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):64-70. PubMed ID: 999403
[TBL] [Abstract][Full Text] [Related]
8. Effects of pretreatment with SKF-525A on triphenyltin metabolism and toxicity in mice.
Ohhira S; Matsui H; Watanabe K
Toxicol Lett; 2000 Nov; 117(3):145-50. PubMed ID: 11087980
[TBL] [Abstract][Full Text] [Related]
9. Psychoactive drugs and stimulus analysis: II. The experimental distinction of stimulus processing and motor effects of drugs.
Johnson FN
Int J Neurosci; 1983 Jul; 20(1-2):11-24. PubMed ID: 6668110
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of the inhibition of rat liver monoamine oxidase-a by clorgyline after pretreatment with SKF 525A.
Fowler CJ
Med Biol; 1980 Oct; 58(5):285-7. PubMed ID: 7206835
[TBL] [Abstract][Full Text] [Related]
11. Interaction of secalonic acid D with phenobarbital, 3-methyl cholanthrene, and SKF-525A in mice.
Reddy CS; Reddy RV; Hayes AW
J Toxicol Environ Health; 1983; 12(4-6):687-94. PubMed ID: 6668617
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mitochondrial oxidative metabolism by SKF-525A in intact cells and isolated mitochondria.
Galeotti T; Eboli ML; Palombini G; van Rossum GD; Kapoor SC
Biochem Pharmacol; 1983 Nov; 32(22):3285-95. PubMed ID: 6651857
[TBL] [Abstract][Full Text] [Related]
13. Psychoactive drugs and stimulus analysis: V. The experimental discrimination of tranquilizing and sedative drugs.
Johnson FN
Int J Neurosci; 1983 Jul; 20(1-2):41-8. PubMed ID: 6668113
[TBL] [Abstract][Full Text] [Related]
14. SKF 525A displaces drugs from serum alpha 1-acid glycoprotein binding sites.
Belpaire FM; Chindavijak B; Bogaert MG
J Pharmacol Exp Ther; 1987 Feb; 240(2):628-30. PubMed ID: 3806415
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of a new psychotherapeutic agent: 4-p-fluorophenyl-5-N(N'-o-methoxyphenyl)piperazinoethyl-4-oxazolin-2-one (LR 511).
Fregnan GB; Vidali M
Pharmacology; 1977; 15(6):485-502. PubMed ID: 563604
[No Abstract] [Full Text] [Related]
16. The cytochrome P450 inhibitor SKF-525A disrupts autophagy in primary rat hepatocytes.
Luo Y; Yang X; Shi Q
Chem Biol Interact; 2016 Aug; 255():55-62. PubMed ID: 26964495
[TBL] [Abstract][Full Text] [Related]
17. Alteration in the magnitude of induction of tyrosine transaminase by glycocorticoids. The effects of phenobarbital, o,p'DDD and beta-diethylaminoethyl diphenylpropylacetate (SKF 525A).
Kupfer D
Arch Biochem Biophys; 1968 Sep; 127(1):200-6. PubMed ID: 4386644
[No Abstract] [Full Text] [Related]
18. Effect of phenobarbital and SKF 525A pretreatment on diphenylhydantoin teratogenicity in mice.
Harbison RD; Becker BA
J Pharmacol Exp Ther; 1970 Nov; 175(2):283-8. PubMed ID: 5481698
[No Abstract] [Full Text] [Related]
19. Alteration in the magnitude of induction of tyrosine transaminase by glucocorticoids. II. Effects of phenobarbital, o,p' DDD and diethylaminoethyl diphenylpropylacetate (SKF 525A) on metabolism of triamcinolone acetonide.
Kupfer D; Partridge R; Jones TM
Arch Biochem Biophys; 1969 Apr; 131(1):57-66. PubMed ID: 4388684
[No Abstract] [Full Text] [Related]
20. Effect of SKF-525A on liver metabolism and hepatotoxicity of tri- and dibutyltin compounds in mice.
Ueno S; Suzuki T; Susa N; Furukawa Y; Sugiyama M
Arch Toxicol; 1997; 71(8):513-8. PubMed ID: 9248630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
